Cilengitide is a molecule designed and synthesized at the Technical University Munich in collaboration with Merck KGaA in Darmstadt. It is based on the cyclic peptide cyclo(-RGDfV-) which is selective for αv integrins which are important in angiogenesis (forming new blood vessels) and other aspects of tumor biology.
This page contains content from the copyrighted Wikipedia article "Cilengitide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
